Rapid Regression of Advanced Hepatocellular Carcinoma Associated with Elevation of Des-Gamma-Carboxy Prothrombin after Short-Term Treatment with Sorafenib – A Report of Two Cases

BACKGROUND: Sorafenib is the first molecular-targeted agent that is effective for advanced hepatocellular carcinoma (HCC), with prolongation of survival. However, a complete response is very rare, and rapid regression of HCC after short-term treatment with sorafenib has not been reported previously....

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Nakazawa, Takahide, Hidaka, Hisashi, Shibuya, Akitaka, Koizumi, Wasaburo
Médium: Artigo
Jazyk:Inglês
Vydáno: S. Karger AG 2010
Témata:
Published: August 2010
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3042023/
https://ncbi.nlm.nih.gov/pubmed/21347197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000319831
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky